ImmunologybioRxivPreprint
Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant
R. Kotaki, Y. Adachi, S. Moriyama…·Y. Takahashi
The paper shows that two doses of mRNA vaccine generate cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant, which are retained and contribute to enhanced antibody responses after a third dose.
DOI 10.1101/2021.12.24.474091